Latest filing published 27 Aug 2019 for BIOLASE, INC, €2,909.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Todd Norbe: trading record in brief
Todd Norbe discloses dealings in Biolase, Inc to SEC (Form 4). In total, 18 filings cover trades dated from 12 December 2018 to 23 August 2019.
Purchases make up the whole of the open-market record (4 purchases, €14k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 14 share grants.
In size, the median ticket on the buying side is €3,550. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The latest filing, published on 27 August 2019, reports a share grant of €238 in Biolase, Inc. The most recent open-market purchase was published on 14 December 2018, 2,887 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Todd Norbe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,687 shares@ US$1.202.1% of flowCommon StockSEC:0001209191-19-047466:0
- 216 shares@ US$1.220.2% of flowCommon StockSEC:0001209191-19-047466:1
- 12,605 shares@ US$1.2210.1% of flowCommon StockSEC:0001209191-19-047174:0
- 643 shares@ US$1.220.5% of flowCommon StockSEC:0001209191-19-047174:1
- 4,800 shares@ US$1.203.8% of flowCommon StockSEC:0001209191-19-047174:2
- 8,045 shares@ US$1.226.5% of flowCommon StockSEC:0001209191-19-047174:3
- 57 shares@ US$1.220.0% of flowCommon StockSEC:0001209191-19-047174:4
- 7,715 shares@ US$1.306.6% of flowCommon StockSEC:0001209191-19-046745:0
- 37 shares@ US$1.250.0% of flowCommon StockSEC:0001209191-19-046745:1
- 4,323 shares@ US$1.223.5% of flowCommon StockSEC:0001209191-19-046745:2
- 4,446 shares@ US$1.524.4% of flowCommon StockSEC:0001209191-19-034956:0
- 948 shares@ US$1.601.0% of flowCommon StockSEC:0001209191-19-034956:1
- 17,594 shares@ US$1.7820.6% of flowCommon StockSEC:0001209191-19-033981:0
- 30,094 shares@ US$1.5530.7% of flowCommon StockSEC:0001209191-19-033981:1
- 5,000 shares@ US$1.033.3% of flowCommon StockSEC:0001209191-18-062820:0Canonical exit: 12 Mar 2019 (T+90)
- 4,100 shares@ US$1.042.7% of flowCommon StockSEC:0001209191-18-062820:1Canonical exit: 13 Mar 2019 (T+90)
- 3,700 shares@ US$1.032.5% of flowCommon StockSEC:0001209191-18-062820:2Canonical exit: 13 Mar 2019 (T+90)
- 2,200 shares@ US$1.021.4% of flowCommon StockSEC:0001209191-18-062820:3Canonical exit: 13 Mar 2019 (T+90)
18 of 18 declarations
